Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1157431
                    [Title] => Simvastatin label now discourages higher dose
                    [Summary] => 
A recommendation against prescribing the highest available dose of simvastatin is among the changes in the labeling information for the drug, the Food and Drug Administration announced.

                    [DatePublished] => 2013-09-01 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

MYOPATHY

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1157431
                    [Title] => Simvastatin label now discourages higher dose
                    [Summary] => 
A recommendation against prescribing the highest available dose of simvastatin is among the changes in the labeling information for the drug, the Food and Drug Administration announced.

                    [DatePublished] => 2013-09-01 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Simvastatin label now discourages higher dose

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | September 1, 2013 - 12:00am

A recommendation against prescribing the highest available dose of simvastatin is among the changes in the labeling information for the drug, the Food and Drug Administration announced.

Opinion